Furthermore, YTHDC1 can bind to m6 A-modified EGF mRNA and promote EGF synthesis, thus enhancing homologous recombination repair(HR) during chemotherapy and leading to adriamycin resistance in breast cancer cells [265]. The gene discussed is EGF; the disease is breast carcinoma.